Scenic Biotech
PrivateLast Round
Series A
Mar 10, 2022
Total Funding Raised
$48.95M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Scenic Biotech operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Series A round in March 2022.
Scenic Biotech is a biotechnology company that develops modifier therapies to treat genetic disorders by identifying genes that suppress disease-causing mutations.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scenic Biotech Comparables
Compare Scenic Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Myllia Biotechnology | 86% | |
| Nucleome Therapeutics | 82% | |
| Enhanced Genomics | 79% |
For institutional investors. Book with your work email.
Scenic Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 10, 2022 | ||||
| Grant | Jun 23, 2020 | ||||
| Series A | Jun 5, 2017 | ||||
| Seed | May 6, 2017 |
For institutional investors. Book with your work email.
Scenic Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMedPartners | Series A |
| Oxford Science Enterprises | Seed, Series A |
| Eir Ventures | Series A |
| Vesalius Biocapital Partners | Series A |
| Oxford Science Enterprises | Series A |
| Inkef Capital | Series A, Seed |
| BioGeneration Ventures | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 407% MoM, reaching 903.
- Jan 7, 2026
Partnered with Ono Pharmaceutical for novel therapeutic target discovery.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 10, 2026
Scenic Biotech appoints Dr. Judith Walker as Chief Medical Officer on Sep 10th '26 in the Netherlands to lead its transition into clinical development and shape its clinical strategy as lead program SC6177 advances toward the clinic in early 2027.
- hiresSep 10, 2026
Scenic Biotech welcomes Dr. Judith Walker as Chief Medical Officer as it prepares to initiate clinical development of SC6177 in early 2027.
For institutional investors. Book with your work email.
Scenic Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Scenic Biotech's valuation, stock price, and market status.
Is Scenic Biotech a public or private company?
Scenic Biotech is a private company.
What is the current stock price of Scenic Biotech?
Scenic Biotech is a private company, so its shares have no public market price. Caplight tracks Scenic Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scenic Biotech worth (valuation)?
Valuation information for Scenic Biotech is not publicly available.
Can I buy Scenic Biotech stock?
Scenic Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scenic Biotech's last funding round?
Scenic Biotech's most recent funding round was Series A on March 10, 2022.
Who are the main investors in Scenic Biotech?
Key investors in Scenic Biotech include BioMedPartners, Eir Ventures, Vesalius Biocapital Partners, Inkef Capital, BioGeneration Ventures.
Will Scenic Biotech IPO soon?
No public IPO plans have been announced for Scenic Biotech.
How can I track Scenic Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Scenic Biotech's shares on secondary markets.